MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETLR CUP HAP 60MM W/ IMPTR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

Model Number 74120160

Device Problem Biocompatibility (2886)

Patient Problems Fistula (1862); Unspecified Infection (1930); Fluid Discharge (2686); Metal Related Pathology (4530)

Event Date 04/27/2021

Event Type  Injury  

Manufacturer Narrative

Internal complaint reference: (b)(4).

Event Description

Us legal, it was reported that, after a left bhr-tha was performed on (b)(6) 2011 due to hypertrophic osteoarthritis, the patient experienced a left infection and inflammatory reaction due to elevated serum cobalt and chromium levels.This adverse event was treated with a left revision surgery on (b)(6) 2021, in which a spacer replacement/synovectomy, bone excision and a trochanteric osteotomy repair were performed.Patient's current health status is unknown.

Manufacturer Narrative

H3, h6: it was reported that left revision surgery was performed due to infection and inflammatory reaction due to elevated serum cobalt and chromium levels.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the acetabular cup, this will continue to be monitored.¿ in the absence of the actual device, the production records were reviewed for the device reportedly involved in this incident.The acetabular cup involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure mode and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the product and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The available medical documents were reviewed.Although it was reported the serum cobalt and chromium levels were elevated, neither the levels nor laboratory reports were provided for review.Without the supporting lab/pathology results, imaging, and/or the analysis of the explanted components, the root cause of the reported events and intraoperative findings cannot be confirmed.It cannot be concluded that the reported clinical reactions were associated with a mal-performance of the implant or implant failure.Based on the available information, including the operative notes, we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the device or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.

Manufacturer Narrative

Additional information: d10 corrected data: e1 (initial reporter name), h6 (health effect - clinical code).

Manufacturer Narrative

H3, h6: it was reported that left revision surgery was performed due to infection and inflammatory reaction due to elevated serum cobalt and chromium levels.As of today, the implanted devices, all of which were used in treatment have not been returned for evaluation.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the acetabular cup, this will continue to be monitored.In the absence of the actual device, the production records were reviewed for the device reportedly involved in this incident.The acetabular cup involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure mode and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the product and similar complaint events was performed.Following the review, no prior applicable escalation actions were identified.The available medical documents were reviewed.Per the surgical technique, the acetabulum is to be reamed to 1-3 mm less than the definitive acetabular component to be inserted depending on the patient¿s size and bone quality.However, the implantation operative report indicated the acetabulum was reamed to 60 mm, the exact size of the acetabular component.It is unknown if the increased reaming of the acetabulum led to accelerated wear and the reported elevated serum cobalt and chromium levels.Although it was reported the serum cobalt and chromium levels were elevated, neither the levels nor laboratory reports were provided for review.The intraoperative findings of draining wound site, devitalized skin and subcutaneous fat, seropurulent drainage and infected & indurated tissue from the acetabular interface is likely from an exogenous nature.It cannot be concluded that the reported clinical reactions were associated with a mal performance of the implant or implant failure.The patient impact is the infection, draining fistula, 2 stage revision and a subsequent 3rd revision.Based on the available information, including the operative notes, we can confirm the reported complaint, however without further information our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the device or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.

• Brand Name: ACETLR CUP HAP 60MM W/ IMPTR
• Type of Device: PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
• Manufacturer (Section D): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer (Section G): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer Contact: holly topping ; 7000 west william cannon drive; austin, TX 78735 ; 5123913905
• MDR Report Key: 14140559
• MDR Text Key: 289488018
• Report Number: 3005975929-2022-00171
• Device Sequence Number: 1
• Product Code: NXT
• UDI-Device Identifier: 03596010502612
• UDI-Public: 03596010502612
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P040033
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Other,Consumer,Health Professional,Company Representative
• Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup,Followup
• Report Date: 04/25/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Expiration Date: 05/01/2016
• Device Model Number: 74120160
• Device Catalogue Number: 74120160
• Device Lot Number: 11EW33044
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Initial Date Manufacturer Received: 03/22/2022
• Initial Date FDA Received: 04/19/2022
• Supplement Dates Manufacturer Received: 09/13/2022; 04/10/2024; 04/24/2024
• Supplement Dates FDA Received: 09/14/2022; 04/17/2024; 04/25/2024
• Was Device Evaluated by Manufacturer?: No
• Date Device Manufactured: 05/14/2011
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: 71309115/11BM11660/SYN POR PLUS HA HO STEM SZ 15; 74222200/10DT41994/MODULAR SLEEVE {} PLUS 0MM 12/1
• Patient Outcome(s): Required Intervention; Hospitalization; Other